101 related articles for article (PubMed ID: 16904193)
1. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.
Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT
J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193
[TBL] [Abstract][Full Text] [Related]
2. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
3. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
Oh SJ; Chung DH
J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
[TBL] [Abstract][Full Text] [Related]
4. A chimeric TCR-beta chain confers increased susceptibility to EAE.
Petersen TR; Lata R; Spittle E; Bäckström BT
Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
[TBL] [Abstract][Full Text] [Related]
5. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
6. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
Ford ML; Evavold BD
Eur J Immunol; 2004 Feb; 34(2):388-97. PubMed ID: 14768043
[TBL] [Abstract][Full Text] [Related]
7. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
[TBL] [Abstract][Full Text] [Related]
8. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
[TBL] [Abstract][Full Text] [Related]
9. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
10. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
11. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.
Falcone M; Rajan AJ; Bloom BR; Brosnan CF
J Immunol; 1998 May; 160(10):4822-30. PubMed ID: 9590229
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
Raikwar HP; Muthian G; Rajasingh J; Johnson C; Bright JJ
J Neuroimmunol; 2005 Oct; 167(1-2):99-107. PubMed ID: 16091293
[TBL] [Abstract][Full Text] [Related]
13. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
Sutton C; Brereton C; Keogh B; Mills KH; Lavelle EC
J Exp Med; 2006 Jul; 203(7):1685-91. PubMed ID: 16818675
[TBL] [Abstract][Full Text] [Related]
14. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice.
Samoilova EB; Horton JL; Chen Y
Cell Immunol; 1998 Nov; 190(1):83-9. PubMed ID: 9826450
[TBL] [Abstract][Full Text] [Related]
15. The IL-10-producing competence of Th2 cells generated in vitro is IL-4 dependent.
Mendel I; Shevach EM
Eur J Immunol; 2002 Nov; 32(11):3216-24. PubMed ID: 12555667
[TBL] [Abstract][Full Text] [Related]
16. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.
Furlan R; Bergami A; Cantarella D; Brambilla E; Taniguchi M; Dellabona P; Casorati G; Martino G
Eur J Immunol; 2003 Jul; 33(7):1830-8. PubMed ID: 12811843
[TBL] [Abstract][Full Text] [Related]
17. Exploiting genotypic differences to identify genes important for EAE development.
Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S
J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174
[TBL] [Abstract][Full Text] [Related]
18. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis.
Suryani S; Sutton I
J Neuroimmunol; 2007 Feb; 183(1-2):96-103. PubMed ID: 17240458
[TBL] [Abstract][Full Text] [Related]
19. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
20. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice.
Küst B; Mantingh-Otter I; Boddeke E; Copray S
J Neuroimmunol; 2006 May; 174(1-2):92-100. PubMed ID: 16519950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
